- Learn the basics
- Find stocks
- Understand a stock
- Compare with peers
Telix Pharmaceuticals Ltd
TLX Australia NASDAQTelix Pharmaceuticals Limited is a clinical-stage biopharmaceutical company that develops and commercializes radiopharmaceutical products for diagnostic imaging and therapeutic use in oncology. Its activities center on small-molecule and biologic agents labeled with radioisotopes that target specific tumor antigens, primarily prostate-specific membrane antigen (PSMA), carbonic anhydrase IX (CAIX), and other cell-surface markers. The company’s lead commercial product, Illuccix (TLX591-CDx), is a gallium-68 PSMA PET imaging agent approved in the United States, Australia, Canada, and certain other markets for the detection and localization of prostate cancer. Telix conducts its operations principally within a single radiopharmaceuticals segment. Its development pipeline includes both diagnostic and therapeutic candidates for prostate cancer, renal cell carcinoma, glioblastoma, and additional solid-tumor indications. Products are manufactured using third-party radiopharmacies and contract manufacturers and are supplied to hospitals, imaging centers, and nuclear-medicine departments in approved jurisdictions.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
The bars show each projection's high and low scenario. The more likely an outcome, the more solid its half of the bar: for the DCF, how often 400 simulations of the company's growth and margins reach that scenario; for the growth plans, up means the plans succeed and no expected decline hits, down means the plans fail and the declines hit. Switch them off with Ranges.
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company, how factual it is and the market mood it conveys (an animal label such as Bull or Bear - hover it for the meaning). What the ratings mean.
More Health Care stocks
- Syntec Optics Holdings, Inc. (OPTXW)
- Tactile Systems Technology Inc (TCMD)
- Takeda Pharmaceutical Co Ltd (TAK)
- Talphera, Inc. (TLPH)
- Tandem Diabetes Care Inc (TNDM)
- Tango Therapeutics, Inc. (TNGX)
- Tarsus Pharmaceuticals, Inc. (TARS)
- Taysha Gene Therapies, Inc. (TSHA)
- Tectonic Therapeutic, Inc. (TECX)
- TELA Bio, Inc. (TELA)
- Teladoc Health, Inc. (TDOC)
- Teleflex Inc (TFX)
- Telomir Pharmaceuticals, Inc. (TELO)
- Tempest Therapeutics, Inc. (TPST)
- Tenax Therapeutics, Inc. (TENX)
- Tenaya Therapeutics, Inc. (TNYA)
- Tenet Healthcare Corp (THC)
- Tenon Medical, Inc. (TNON)
- Tenon Medical, Inc. (TNONW)
- Terns Pharmaceuticals, Inc. (TERN)
- Teva Pharmaceutical Industries Ltd (TEVA)
- Tevogen Inc. (TVGN)
- Tevogen Inc. (TVGNW)
- Tg Therapeutics, Inc. (TGTX)